Aytu BioPharma, Inc. Share Price
NASDAQ: AYTU | Micro CapAytu BioPharma, Inc. Stock Performance
Open $2.25 | Prev. Close $2.29 | Circuit Range N/A |
Day Range $2.25 - $2.28 | Year Range $1.68 - $3.00 | Volume 751 |
Average Traded $2.27 |
Aytu BioPharma, Inc. Share Price Today
As of 9 August 2026, Aytu BioPharma, Inc.'s share price is $2.30. The stock opened at $2.25, compared to its previous close of $2.29. During today's trading session, Aytu BioPharma, Inc.'s share price traded between $2.25 and $2.28, with an average price of $2.26. Over the past 52 weeks, the stock has recorded a high of $3.00 and a low of $1.68. In terms of performance, Aytu BioPharma, Inc.'s share price has declined by 10.85% over the last six months and is down 0.86% on a year-on-year basis.
Aytu BioPharma, Inc. Share Price Chart
Aytu BioPharma, Inc. Stock Fundamentals & Key Indicators
Market Cap $14.44M | PE Ratio (TTM) -1.06 | Dividend Yield N/A |
EPS (TTM) $-2.16 | Revenue (TTM) $66.38M | Return On Equity (TTM) -74.78% |
Profit Margin -21.36% | Debt to Equity 3.33 | Quarterly Earnings Growth YoY N/A |
Aytu BioPharma, Inc. Quarterly Profit & Loss
All figures in USD
Aytu BioPharma, Inc. Annual Profit & Loss
All figures in USD
About Aytu BioPharma, Inc.
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above, and Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Aytu BioPharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.27 | $2.29 | +1.78% |
Jul 2026 | $2.13 | $2.25 | +4.17% |
Jun 2026 | $2.13 | $2.16 | -5.47% |
May 2026 | $2.56 | $2.29 | -10.92% |
Apr 2026 | $2.67 | $2.56 | -6.39% |
Mar 2026 | $2.52 | $2.74 | +6.20% |
Feb 2026 | $2.68 | $2.58 | -0.77% |
Jan 2026 | $2.75 | $2.60 | -0.38% |
Dec 2025 | $2.14 | $2.61 | +22.54% |
Nov 2025 | $2.25 | $2.13 | -2.96% |
Oct 2025 | $1.95 | $2.19 | +17.38% |
Sep 2025 | $2.31 | $1.87 | -19.40% |